The term cardiomyopathy refers to a variety of conditions in which the heart muscle becomes weakened or abnormally thickened, affecting its ability to pump blood effectively. Cardiomyopathies can be either inherited or acquired, with genetic mutations often playing a significant role in conditions like hypertrophic cardiomyopathy. As these diseases progress, they may lead to arrhythmias or heart failure, making early intervention crucial. Management strategies typically involve a combination of medications, lifestyle adjustments, and monitoring to prevent complications. In some cases, patients may require devices like pacemakers or even a heart transplant. With greater awareness and advancements in treatment, cardiomyopathies are becoming more manageable, offering hope for affected individuals.
Title : Revolutionizing CKD care: How finerenone transforms outcomes in heart and kidney health - Insights from fidelio-DKD
Robert J Chilton, University of Texas Health Science Center San Antonio, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options for pulmonary hypertension and right heart failure
Yong Xiao Wang, Albany Medical Center, United States
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : Post-cardiotomy ECMO (PC-ECMO)
Gustavo Lionel Knop, Mayo Clinic, United States
Title : The past, present and future of AI in cardiology
Narendra Kumar, HeartbeatsZ Academy, United Kingdom